Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousBone Marrow TransplantationGraft vs Host DiseaseTransplantation ConditioningAntineoplastic Combined Chemotherapy ProtocolsHematopoietic Stem Cell MobilizationCombined Modality TherapyBone MarrowCyclophosphamideTreatment OutcomeGranulocyte Colony-Stimulating FactorLeukapheresisBone Marrow CellsHematopoietic Stem CellsStem CellsHematologic NeoplasmsBlood Component RemovalAntigens, CD34Stem Cell TransplantationAntineoplastic AgentsImmunosuppressive AgentsLymphoma, Non-HodgkinMelphalanGraft SurvivalMultiple MyelomaTissue DonorsSalvage TherapyBusulfanBone and BonesBlood CellsRecurrenceCord Blood Stem Cell TransplantationBone Marrow DiseasesEtoposideBlood Cell CountChemotherapy, AdjuvantHematopoiesisBone Marrow PurgingWhole-Body IrradiationHistocompatibilityTransplantation ChimeraTime FactorsHistocompatibility TestingMyeloablative AgonistsAntineoplastic Agents, AlkylatingLeukemiaCytomegalovirus InfectionsDisease-Free SurvivalRemission InductionRetrospective StudiesSurvival RateThiotepaSurvival AnalysisAnemia, AplasticFlow CytometryLeukemia, Myeloid, AcuteOpportunistic InfectionsIfosfamideNeoplasmsDose-Response Relationship, DrugCytarabineHematologic DiseasesHodgkin DiseaseInfectionBlood DonorsImmunocompromised HostColony-Forming Units AssayCell DifferentiationCell SeparationDoxorubicinTransplantationVidarabinePlatelet CountCells, CulturedLymphomaLeukemia, Myelogenous, Chronic, BCR-ABL PositiveFollow-Up StudiesImmunophenotypingRecombinant ProteinsLeukocyte CountTransplantation, IsogeneicT-LymphocytesPrecursor Cell Lymphoblastic Leukemia-LymphomaLymphocyte DepletionProspective StudiesEmbryonic Stem CellsFatal OutcomeLeukocytes, MononuclearMyelodysplastic SyndromesNeutropeniaAcute DiseaseLeukocyte TransfusionPrognosisAdult Stem CellsCarmustineBone RemodelingFeasibility Studies